Leptomeningeal and Intraparenchymal Blood Barrier Disruption in a MOG-IgG Positive Patient

Leptomeningeal and Intraparenchymal Blood Barrier Disruption in a MOG-IgG Positive Patient

Background. A serum immunoglobulin G (IgG) autoantibody specific for the myelin oligodendrocyte glycoprotein (MOG) is detected in the subgroup patients with inflammatory demyelinating diseases of the central nervous system (CNS). However, whether MOG-IgG contributes to blood-brain barrier (BBB) impa...

Full description

Bibliographic Details
Main Authors:	Sayed Hamid Mohseni, Hanne Pernille Bro Skejoe, Jens Wuerfel, Friedemann Paul, Markus Reindl, Nasrin Asgari
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	Case Reports in Neurological Medicine
Online Access:	http://dx.doi.org/10.1155/2018/1365175

Similar Items

Recent developments in MOG-IgG associated neurological disorders
by: Harald Hegen, et al.
Published: (2020-07-01)

Bilateral symmetrical deep gray matter involvement and leptomeningeal enhancement in a child with MOG-IgG-associated encephalomyelitis
by: Weibing Shen, et al.
Published: (2021-01-01)

MOG-IgG associated optic neuritis is not multiple sclerosis
by: Bruna Klein da Costa, et al.

Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel
by: Livnat Brill, et al.
Published: (2021-01-01)

Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study
by: Felix A. Schmidt, et al.
Published: (2020-09-01)

Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method
by: Luca Bollo, et al.
Published: (2021-03-01)

Optic neuritis of MOG-IgG-associated autoimmune disorders: a case report
by: Tiantian Li, et al.
Published: (2021-01-01)

Microfluidic system evaluation for the semi-automatic detection of MOG-IgG in serum samples
by: Numfon Khemthongcharoen, et al.
Published: (2021-12-01)

Overlapping syndrome mimicking infectious meningoencephalitis in a patient with MOG and GFAP IgG
by: Suqiong Ji, et al.
Published: (2021-09-01)

MOG-IgG- versus AQP4-IgG-Positive Optic Neuritis in Thailand: Clinical Characteristics and Long-Term Visual Outcomes Comparison
by: Narongkhananukul C, et al.
Published: (2020-11-01)

Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study.
by: Hadas Stiebel-Kalish, et al.
Published: (2017-01-01)

Myelin Oligodendrocyte Glycoprotein (MOG)-IgG associated demyelinating disease: Our experience with this distinct syndrome
by: Shripad S Pujari, et al.
Published: (2021-01-01)

MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature
by: S. Jarius, et al.
Published: (2018-03-01)

Estudo longitudinal dos aspectos clínicos, laboratoriais e imagenológicos de pacientes MOG-IgG positivo
by: Salles, Luana Michelli Oliveira de Paula
Published: (2019)

Relapsing optic neuritis and meningoencephalitis in a child: case report of delayed diagnosis of MOG-IgG syndrome
by: Xiaonan Zhong, et al.
Published: (2019-05-01)

AQP4-IgG and MOG-IgG Related Optic Neuritis—Prevalence, Optical Coherence Tomography Findings, and Visual Outcomes: A Systematic Review and Meta-Analysis
by: Angeliki G. Filippatou, et al.
Published: (2020-10-01)

Detection of MOG-IgG in Clinical Samples by Live Cell-Based Assays: Performance of Immunofluorescence Microscopy and Flow Cytometry
by: Amanda Marchionatti, et al.
Published: (2021-05-01)

MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder
by: Giordani Rodrigues dos Passos, et al.
Published: (2018-04-01)

Possible coexistence of MOG-IgG-associated disease and anti-Caspr2 antibody-associated autoimmune encephalitis: a first case report
by: Pei Liu, et al.
Published: (2020-10-01)

Comparison of spontaneous brain activity revealed by regional homogeneity in AQP4-IgG neuromyelitis optica-optic neuritis versus MOG-IgG optic neuritis patients: a resting-state functional MRI study
by: Wang J, et al.
Published: (2017-10-01)

Influence of type I IFN signaling on anti-MOG antibody-mediated demyelination
by: Carsten Tue Berg, et al.
Published: (2017-06-01)

Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis
by: Nadja Borisow, et al.
Published: (2018-10-01)

Rebound of relapses after discontinuation of rituximab in a patient with MOG-IgG1 positive highly relapsing optic neuritis: a case report
by: Seok-Jin Choi, et al.
Published: (2018-12-01)

Selective localization of IgG from cerebrospinal fluid to brain parenchyma
by: Marlene Thorsen Mørch, et al.
Published: (2018-04-01)

Myelin oligodendrocyte glycoprotein-antibody (MOG-IgG) associated disease with centrally located long spinal cord lesion in a 14-month old child
by: Mohamad Syafeeq Faeez Md Noh
Published: (2020-09-01)

Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related disease
by: Lucas A. Schulte, et al.
Published: (2020-08-01)

MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome
by: Sara Mariotto, et al.
Published: (2017-10-01)

Intraparenchymal schwannoma of the frontal lobe.
by: Deogaonkar M, et al.
Published: (1994-10-01)

Intraparenchymal clear cell ependymoma
by: Prabal Deb, et al.
Published: (2011-01-01)

Intraparenchymal meningioma in a child
by: C Werbrouck, et al.
Published: (2014-01-01)

Purificación de IgG1, IgG2 e IgG3 mediante cromatografía de afinidad a partir de intacglobín Purification of IgG1, IgG2 and IgG3 by affinity chromatography starting from Intacglobin
by: Ada A Arce Hernández, et al.
Published: (2001-08-01)

MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.
by: Inga Koneczny, et al.
Published: (2013-01-01)

The Expression of IgG and IgG4 in Orbital MALT Lymphoma: The Similarities and Differences of IgG4-Related Diseases
by: Li KM, et al.
Published: (2020-06-01)

Anti myelin oligodendrocyte glycoprotein associated immunoglobulin G (AntiMOG-IgG)-associated neuromyelitis optica spectrum disorder with persistent disease activity and residual cognitive impairment
by: Lekha Pandit, et al.
Published: (2017-01-01)

Profile of total IgG, IgG1, IgG2, IgG3 and IgG4 levels in sera of patients with paracoccidioidomycosis: treatment follow-up using Mexo and rPb27 as antigens in an ELISA
by: Lílian da Silva Santos, et al.
Published: (2012-02-01)

Factors associated with IgG levels in adults with IgG subclass deficiency
by: James C. Barton, et al.
Published: (2021-08-01)

Epidemiology of neuromyelitis optica spectrum disorder in Denmark (1998–2008, 2007–2014)
by: Nasrin Asgari, et al.
Published: (2019-07-01)

IgG4/IgG RNA ratio does not accurately discriminate IgG4-related disease from pancreatobiliary cancer
by: Elsemieke de Vries, et al.
Published: (2020-08-01)

Intraparenchymal hemorrhage after electroconvulsive therapy
by: Elizabeth W.J. Carlson, et al.
Published: (2017-09-01)

Characterization of patients with spontaneous intraparenchymal hemorrhage
by: Anibal González Hernández, et al.
Published: (2019-06-01)

Cannot write session to /tmp/vufind_sessions/sess_6m51asj3qkv81sqerh3ebk5ajf